290 related articles for article (PubMed ID: 24587363)
1. Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.
Rytelewski M; Meilleur CE; Yekta MA; Szabo PA; Garg N; Schell TD; Jevnikar AM; Sharif S; Singh B; Haeryfar SM
PLoS One; 2014; 9(2):e90439. PubMed ID: 24587363
[TBL] [Abstract][Full Text] [Related]
2. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
Curran TA; Jalili RB; Farrokhi A; Ghahary A
Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection.
Fox JM; Sage LK; Huang L; Barber J; Klonowski KD; Mellor AL; Tompkins SM; Tripp RA
J Gen Virol; 2013 Jul; 94(Pt 7):1451-1461. PubMed ID: 23580425
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-Cells Mediate IFN-α-Induced Resistance against Antigen-Induced Arthritis.
Chenna Narendra S; Chalise JP; Biggs S; Kalinke U; Magnusson M
Front Immunol; 2018; 9():285. PubMed ID: 29515584
[TBL] [Abstract][Full Text] [Related]
5. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.
Eleftheriadis T; Pissas G; Sounidaki M; Tsogka K; Antoniadis N; Antoniadi G; Liakopoulos V; Stefanidis I
Int J Mol Med; 2016 Nov; 38(5):1605-1613. PubMed ID: 27667153
[TBL] [Abstract][Full Text] [Related]
7. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
[TBL] [Abstract][Full Text] [Related]
8. Origins and functional basis of regulatory CD11c+CD8+ T cells.
Vinay DS; Kim CH; Choi BK; Kwon BS
Eur J Immunol; 2009 Jun; 39(6):1552-63. PubMed ID: 19499519
[TBL] [Abstract][Full Text] [Related]
9. Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.
Feunou P; Vanwetswinkel S; Gaudray F; Goldman M; Matthys P; Braun MY
J Immunol; 2007 Jul; 179(2):910-7. PubMed ID: 17617582
[TBL] [Abstract][Full Text] [Related]
10. Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection.
Huang L; Li L; Klonowski KD; Tompkins SM; Tripp RA; Mellor AL
PLoS One; 2013; 8(6):e66546. PubMed ID: 23785507
[TBL] [Abstract][Full Text] [Related]
11. Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells.
Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
Mol Cell Biochem; 2008 Feb; 309(1-2):1-7. PubMed ID: 18008147
[TBL] [Abstract][Full Text] [Related]
12. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge.
Sage LK; Fox JM; Mellor AL; Tompkins SM; Tripp RA
Viral Immunol; 2014 Apr; 27(3):112-23. PubMed ID: 24702331
[TBL] [Abstract][Full Text] [Related]
14. Discordant rearrangement of primary and anamnestic CD8+ T cell responses to influenza A viral epitopes upon exposure to bacterial superantigens: Implications for prophylactic vaccination, heterosubtypic immunity and superinfections.
Meilleur CE; Memarnejadian A; Shivji AN; Benoit JM; Tuffs SW; Mele TS; Singh B; Dikeakos JD; Topham DJ; Mu HH; Bennink JR; McCormick JK; Haeryfar SMM
PLoS Pathog; 2020 May; 16(5):e1008393. PubMed ID: 32433711
[TBL] [Abstract][Full Text] [Related]
15. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR
J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
Curti A; Pandolfi S; Valzasina B; Aluigi M; Isidori A; Ferri E; Salvestrini V; Bonanno G; Rutella S; Durelli I; Horenstein AL; Fiore F; Massaia M; Colombo MP; Baccarani M; Lemoli RM
Blood; 2007 Apr; 109(7):2871-7. PubMed ID: 17164341
[TBL] [Abstract][Full Text] [Related]
17. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
18. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.
Sharma MD; Hou DY; Baban B; Koni PA; He Y; Chandler PR; Blazar BR; Mellor AL; Munn DH
Immunity; 2010 Dec; 33(6):942-54. PubMed ID: 21145762
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated expression of indoleamine 2,3-dioxygenase 1 in non-Hodgkin lymphoma correlates with increased regulatory T-cell infiltration.
Liu XQ; Lu K; Feng LL; Ding M; Gao JM; Ge XL; Wang X
Leuk Lymphoma; 2014 Feb; 55(2):405-14. PubMed ID: 23682557
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities.
Haeryfar SM; DiPaolo RJ; Tscharke DC; Bennink JR; Yewdell JW
J Immunol; 2005 Mar; 174(6):3344-51. PubMed ID: 15749866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
